To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
Age ≥ 18 years
Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
Ability to understand and willingness to sign written informed consent
History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.
M D Anderson Cancer Center
Cohort
Prospective
Standard of Care
BehavioralStandard of care assessment of their function including pituitary hormone lab draws, audiogram hearing test, eye exam, teeth and jaw exam (in trismus clinic) and speech and swallowing evaluation
MD Anderson Symptom Inventory Head and Neck Module (MDASI-HN)
MD Anderson Symptom Inventory Head and Neck Module (MDASI-HN) is a disease specific PRO instrument validated for patients with head and neck cancer. It is the most commonly utilized instrument in the head and neck cancer population, of which sinonasal and nasopharyngeal tumors are disease subsites. Score scale from 0 (symptom has been present) to 10 (the symptom was as bad as you can imagine it could be)
Click on the lead sponsor to view all of their trials.
